BIOMAT Database Logo BIOMAT Database Logo

Inhibition of brain type A monoamine oxidase and 5-hydroxytryptamine uptake by two amphetamine metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine. 1990

Y Arai, and S K Kim, and H Kinemuchi, and T Tadano, and S E Satoh, and N Satoh, and K Kisara
Department of Pharmacology, School of Medicine, Showa University, Tokyo, Japan.

Two amphetamine metabolites, p-hydroxyamphetamine (p-OHA) and p-hydroxynorephedrine (p-OHN), selectively inhibited the A form of monoamine oxidase (MAO) in rat and mouse forebrain homogenates. Of these two metabolites, p-OHA inhibited MAO-A more strongly than p-OHN. This MAO-A-selective inhibition by p-OHA or p-OHN was found to be competitive with respect to deamination of its substrate, 5-hydroxytryptamine (5-HT). The degree of MAO-A inhibition was not changed by 90 min of preincubation of the enzyme preparations with either metabolite, and the activity inhibited by p-OHA after the preincubation recovered completely to the control level after repeated washing. Uptake of 5-HT or dopamine into mouse forebrain synaptosomes was highly reduced by both p-OHA and p-OHN. Both metabolites were more potent in reducing dopamine uptake than in reducing 5-HT uptake. In reduction of 5-HT and of dopamine uptake, p-OHA was more potent than p-OHN. These results indicate that p-OHA is a more selective inhibitor of brain MAO-A activity and 5-HT uptake than its subsequent metabolite, p-OHN. These two actions of p-OHA might, together with possible 5-HT efflux into the synaptic cleft, greatly contribute to head twitch, a brain 5-HT-mediated animal behavior induced by p-OHA.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D010136 p-Hydroxyamphetamine Amphetamine metabolite with sympathomimetic effects. It is sometimes called alpha-methyltyramine, which may also refer to the meta isomer, gepefrine. Hydroxyphenylisopropylamine,Methyltyramine,Norpholedrin,Oxyamphetamine,para-Hydroxyamphetamine,Hydroxyamfetamine,Hydroxyamphetamin,Hydroxyamphetamine,Hydroxyamphetamine Hydrobromide,Paredrine,Hydrobromide, Hydroxyamphetamine,p Hydroxyamphetamine,para Hydroxyamphetamine
D010137 p-Hydroxynorephedrine Parahydroxy analog of phenylpropanolamine with properties as a sympathomimetic. para-Hydroxynorephedrine,p Hydroxynorephedrine,Hydroxynorephedrine, p,para Hydroxynorephedrine
D010665 Phenylpropanolamine A sympathomimetic that acts mainly by causing release of NOREPINEPHRINE but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant. Norephedrine,Dexatrim,Phenylpropanolamine Hydrochloride,Prolamine,Propagest,Triaminic DM,Hydrochloride, Phenylpropanolamine
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004027 Diencephalon The paired caudal parts of the PROSENCEPHALON from which the THALAMUS; HYPOTHALAMUS; EPITHALAMUS; and SUBTHALAMUS are derived. Interbrain,Interbrains
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine

Related Publications

Y Arai, and S K Kim, and H Kinemuchi, and T Tadano, and S E Satoh, and N Satoh, and K Kisara
Selective inhibition of MAO-A in serotonergic synaptosomes by two amphetamine metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine.
January 1990, Neurochemistry international,
Y Arai, and S K Kim, and H Kinemuchi, and T Tadano, and S E Satoh, and N Satoh, and K Kisara
A comparison of the effects of amphetamine and its metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine, on uptake, release and catabolism of 3H-norepinephrine in cerebral cortex of rat brain.
June 1974, The Journal of pharmacology and experimental therapeutics,
Y Arai, and S K Kim, and H Kinemuchi, and T Tadano, and S E Satoh, and N Satoh, and K Kisara
Displacement of brain and heart noradrenaline by p-hydroxynorephedrine after administration of p-hydroxyamphetamine.
January 1971, Acta pharmacologica et toxicologica,
Y Arai, and S K Kim, and H Kinemuchi, and T Tadano, and S E Satoh, and N Satoh, and K Kisara
Formation of p-hydroxynorephedrine in brain following intraventricular administration of p-hydroxyamphetamine.
December 1974, Neuropharmacology,
Y Arai, and S K Kim, and H Kinemuchi, and T Tadano, and S E Satoh, and N Satoh, and K Kisara
Blood pressure and heart rate response evoked by p-hydroxyamphetamine and by p-hydroxynorephedrine II. A quantitative assessment of the role of amphetamine metabolites in acute responses evoked by d-amphetamine.
June 1980, The Journal of pharmacology and experimental therapeutics,
Y Arai, and S K Kim, and H Kinemuchi, and T Tadano, and S E Satoh, and N Satoh, and K Kisara
Inhibition of human brain type A and B monoamine oxidase by chloropromazine and metabolites.
January 1979, Communications in psychopharmacology,
Y Arai, and S K Kim, and H Kinemuchi, and T Tadano, and S E Satoh, and N Satoh, and K Kisara
Inhibition of mouse brain monoamine oxidase by (+)-amphetamine in vivo.
April 1978, The Journal of pharmacy and pharmacology,
Y Arai, and S K Kim, and H Kinemuchi, and T Tadano, and S E Satoh, and N Satoh, and K Kisara
Toxicity of the amphetamine metabolites 4-hydroxyamphetamine and 4-hydroxynorephedrine in human dopaminergic differentiated SH-SY5Y cells.
March 2017, Toxicology letters,
Y Arai, and S K Kim, and H Kinemuchi, and T Tadano, and S E Satoh, and N Satoh, and K Kisara
A specific gas chromatographic method for the detection of p-hydroxyamphetamine and p-hydroxynorephedrine in brain tissue.
September 1973, Journal of chromatography,
Y Arai, and S K Kim, and H Kinemuchi, and T Tadano, and S E Satoh, and N Satoh, and K Kisara
Platelet monoamine oxidase activity and 5-hydroxytryptamine uptake in agoraphobic patients.
November 1989, The British journal of psychiatry : the journal of mental science,
Copied contents to your clipboard!